Tourmaline Bio Inc. Income Statement
Concept
Total Revenue
YoY
Cost of Goods Sold (COGS)
Gross Profit
Operating expenses
Selling, General & Administrative
Research & Development
Operating Income
Interest Expense
Income Before Tax
Tax Provision
Net Income
YoY
Total Expenses
Net Interest Income
EBITDA
Reconciled Depreciation
EBIT
2023
2022
0M
-
0M
0M
45M
13M
32M
-45M
0M
-42M
0M
-42M
113.82%
0M
0M
0M
0M
0M
0M
-
0M
0M
20M
2M
18M
-20M
0M
-20M
0M
-20M
113.82%
0M
0M
0M
0M
0M
Concept
Total Revenue
YoY
Cost of Goods Sold (COGS)
Gross Profit
Operating expenses
Selling, General & Administrative
Research & Development
Operating Income
Interest Expense
Income Before Tax
Tax Provision
Net Income
YoY
Total Expenses
Net Interest Income
EBITDA
Reconciled Depreciation
EBIT
4Q2023
3Q2023
4Q2022
3Q2022
0M
-
0M
0M
6M
-8M
15M
-6M
0M
2M
0M
2M
113.82%
0M
0M
0M
-1M
0M
0M
-
0M
0M
9M
9M
0M
-9M
0M
-7M
0M
-7M
113.82%
0M
2M
0M
1M
0M
0M
-
0M
0M
-37M
12M
25M
37M
0M
36M
0M
36M
113.82%
0M
0M
0M
-2M
0M
0M
-
0M
0M
20M
5M
15M
-20M
0M
-19M
0M
-19M
113.82%
0M
1M
0M
2M
0M